LCN2 and pancreatic adenocarcinoma: In the gene set enrichment analysis in PAAD patients from TCGA, we found that the JAK/STAT3 signaling pathway, which was reported to induce CXCL1 expression,33 was significantly enriched in both BICC1 high patients and LCN2 high patients (Fig. 6a).